Clinical outcomes and predictors in patients with acute on chronic liver failure in Southern Taiwan

被引：0
作者：
Huang, Pao-Yuan [1 ]
Lin, Yu-Cheng [2 ]
Wang, Chih-Chi [2 ]
Chen, Chien-Hung [1 ]
机构：
[1] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol,Coll Med, Taoyuan City, Taiwan
[2] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Surg, Div Gen Surg,Coll Med, Taoyuan City, Taiwan
来源：
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2025年 / 124卷 / 03期
关键词：
Acute-on-chronic liver failure; AARC; CLIF-C ACLF score; COSSH-ACLF score; ACUTE DECOMPENSATION; MORTALITY; TRANSPLANTATION; MODEL; SCORE; ACLF; MELD;
D O I：
10.1016/j.jfma.2024.08.034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background/aims: The study is to analyze the clinical characteristics and identify prognostic factors as well as evaluate predictive models in patients with acute-on-chronic liver failure (ACLF) from Southern Taiwan. Methods: The cohort study was conducted using the Chang Gung Research Database. We included patients with ACLF based on the definition provided by the Asian-Pacific Association for the Study of the Liver ACLF Research Consortium (AARC). Results: A total of 231 patients diagnosed with ACLF were included in this study, out of which 26 patients underwent liver transplantation (LT). The primary cause of ACLF was acute exacerbation of hepatitis B virus (HBV) in 68.4% of cases and followed by severe alcoholic hepatitis (20.8%). Among LT-free patients, the 28-day mortality rate was observed to be 31%. Older age, higher INR and ammonia levels, and the presence of severe hepatic encephalopathy on 3-6 days of treatment were independent predictors of 28-day mortality. The CLIF-C ACLF and COSSH-ACLF scores, evaluated on 3-6 days, demonstrated the highest predictive performance for 28-day mortality. The optimal cut-off values for the CLIF-C ACLF and COSSH-ACLF scores were determined to be 47 and 6.3, respectively. Patients with CLIF-C ACLF score >63 or COSSH-ACLF score >8.1 experienced 100% mortality by day 28. Conclusion: The CLIF-C ACLF and COSSH-ACLF scores, evaluated within one week after treatment, exhibit strong predictive capabilities for short-term mortality in ACLF patients. These models are valuable tools for guiding timely decision-making, including the consideration of liver transplantation or withdrawal from treatment.
引用
收藏
页码：234 / 240
页数：7
相关论文
共 24 条
  • [1] Moreau R., Jalan R., Gines P., Et al., Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology, 144, 7, pp. 1426-1437, (2013)
  • [2] Sarin S.K., Choudhury A., Sharma M.K., Et al., Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update, Hepatol Int, 13, 4, pp. 353-390, (2019)
  • [3] Arroyo V., Moreau R., Kamath P.S., Et al., Acute-on-chronic liver failure in cirrhosis, Nat Rev Dis Prim, 2, (2016)
  • [4] Bernsmeier C., Pop O.T., Singanayagam A., Et al., Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK, Gastroenterology, 148, 3, pp. 603-615 e614, (2015)
  • [5] Bahirwani R., Shaked O., Bewtra M., Forde K., Reddy K.R., Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes, Transplantation, 92, 8, pp. 952-957, (2011)
  • [6] Chan A.C., Fan S.T., Criteria for liver transplantation in ACLF and outcome, Hepatol Int, 9, 3, pp. 355-359, (2015)
  • [7] Reddy M.S., Rajalingam R., Rela M., Liver transplantation in acute-on-chronic liver failure: lessons learnt from acute liver failure setting, Hepatol Int, 9, 4, pp. 508-513, (2015)
  • [8] Jalan R., Saliba F., Pavesi M., Et al., Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure, J Hepatol, 61, 5, pp. 1038-1047, (2014)
  • [9] Crabb D.W., Bataller R., Chalasani N.P., Et al., Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia, Gastroenterology, 150, 4, pp. 785-790, (2016)
  • [10] Thursz M., Morgan T.R., Treatment of severe alcoholic hepatitis, Gastroenterology, 150, 8, pp. 1823-1834, (2016)
123